| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439236 | EBioMedicine | 2016 | 11 Pages |
Abstract
Our 10-miRNA-based classifier provides a reliable prognostic model for disease recurrence in HRÂ +Â HER2Â â breast cancer patients. This model may facilitate personalized therapy-decision making for HRÂ +Â HER2Â â individuals.
Keywords
IRBCSCsBCSCsROCmiRNAsHER2AUCFFPEIHCImmunohistochemistryEMTBreast conserving surgeryLeast absolute shrinkage and selection operatorEndocrine therapyBCsmicroRNAsBreast cancer stem cellBreast cancer stem cellsCancer stem cellsClassifierformalin-fixed paraffin-embeddedarea under curveMiRNARecurrence scoreinstitutional review boardprognosisLASSOEpithelial-mesenchymal transitionEstrogen receptorreceiver operating characteristicHuman epidermal growth factor receptor 2hormone receptorProgesterone receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Chang Gong, Weige Tan, Kai Chen, Na You, Shan Zhu, Gehao Liang, Xinhua Xie, Qian Li, Yunjie Zeng, Nengtai Ouyang, Zhihua Li, Musheng Zeng, ShiMei Zhuang, Wan-Yee Lau, Qiang Liu, Dong Yin, Xueqin Wang, Fengxi Su, Erwei Song,